SoPro: Monitor GLP-1

Name: SoPro: Monitor GLP-1 revenue & download estimates
Creator: AppCurrents

App Store·MedicalFree★ 0.00 (0)launched 3mo agoapp updated 16d agocharts in 1 country

Scout Score

SoPro: Monitor GLP-1 generates an estimated $0/month in revenue from 0 downloads/month on the App Store, according to AppCurrents estimates (updated 2026-08-02).

Estimates updated 02.08.2026 · How we estimate · Ranges reflect model confidence, not exact figures.
Est. revenue / month	$0
Est. downloads / month	0
Estimate confidence	low
Pricing	Free
Rating	0.00 ★ (0 ratings)
Category	Medical
Released	16.04.2026
App last updated	19.07.2026
Platform	iOS

Est. downloads / mo

Est. revenue / mo

Rating velocity / day

Chart velocity

—

Peak rank

—

Days tracked

—

Modeled monthly estimate · rating velocity · low confidence

About

Sopro is the companion app for people on GLP-1 treatment (Ozempic, Ozivy, Mounjaro, Wegovy, Rybelsus and similar medications). Log your doses, track your weight, symptoms and appetite — all in one app designed for patients who want clarity and control over their treatment. EFFORTLESS DOSE LOGGING Smart reminders on your injection day, with tolerance for unexpected delays. Multiple schedules for t…

View on the App Store →

Trends & analysis

Chart rank trend

US · overall

Collecting rank history — no snapshots so far. Fills in twice daily.

Why it's surfacing

Scout 21

Newness

Breakout

Ratings & velocity

★ 0 in window

Total ratings

Jun 22Jul 28

New ratings / day

Jul 3Jul 28

Geographic reach

best rank · 1 storefront

#60 category

Revenue & downloads trend

monthly estimate

Est. revenue / mo · $0

Jun 22Jul 26

Est. downloads / mo · 0

Jun 22Jul 26

Update history

3 updates tracked

v1.6.016d ago
We've fixed bugs and made performance improvements to provide a smoother, more reliable experience.
v1.5.026d ago
- Improved English and Spanish translations. - Expanded information about potential side effects. - Added a reminder to rotate the application site after each application.
v1.41mo ago
Now with Ozivy in the catalog — Brazil's first domestic semaglutide. Add your treatment in seconds and keep tracking doses, weight, and cost as always. We also improved dose-logging stability and fixed minor display tweaks.